AstraZeneca COVID-19 vaccine authorized for emergency use by World Health Organization
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Focusing on innate immunity opens way for precision medicine approaches to AD
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing
The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination
Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others
Advancement can enable greater certainty for providers and better outcomes for patients
Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus
The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases
The collaboration aims to advance the scale-up of hMSC manufacturing for regenerative medicine
Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics
The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments
The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years
The new institute aims to meet the urgent need to do more research into the antimicrobial resistance
Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF